AEON Biopharma, Inc.
AEON
$0.88
$0.00-0.23%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.49M | 2.33M | 3.26M | 3.13M | 2.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.10M | 2.93M | 4.32M | 3.95M | 5.67M |
| Operating Income | -5.10M | -2.93M | -4.32M | -3.95M | -5.67M |
| Income Before Tax | -37.14M | -4.54M | -6.64M | 9.10M | 2.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.14M | -4.54M | -6.64M | 9.10M | 2.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.14M | -4.54M | -6.64M | 9.10M | 2.08M |
| EBIT | -5.10M | -2.93M | -4.32M | -3.95M | -5.67M |
| EBITDA | -5.08M | -2.91M | -4.30M | -3.93M | -5.64M |
| EPS Basic | -2.88 | -0.39 | -0.60 | 2.28 | 3.76 |
| Normalized Basic EPS | -0.93 | -0.17 | -0.27 | 1.14 | -5.35 |
| EPS Diluted | -2.88 | -0.39 | -0.60 | 2.28 | 3.74 |
| Normalized Diluted EPS | -0.93 | -0.17 | -0.27 | 1.14 | -5.34 |
| Average Basic Shares Outstanding | 12.89M | 11.63M | 11.09M | 3.98M | 554.30K |
| Average Diluted Shares Outstanding | 12.89M | 11.63M | 11.09M | 3.98M | 555.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |